Oligodendroglial tumours (Q88055): Difference between revisions
From determinar.ia.br - Determine suas informações
Created a new Item |
Changed label, description and/or aliases in pt-br, en |
||
| description / pt-br | description / pt-br | ||
Neoplasia do sistema nervoso central composta predominantemente por células morfologicamente semelhantes a oligodendróglias. Os tumores oligodendrogliais histologicamente compreendem um espectro contínuo que varia de neoplasias bem diferenciadas a tumores francamente malignos. O sistema de classificação da OMS reconhece dois graus de malignidade: grau II da OMS para tumores bem diferenciados (oligodendroglioma) e grau III da OMS para oligodendroglioma anaplásico. (Adaptado da OMS) | |||
| description / en | description / en | ||
A neoplasm of the central nervous system composed predominantly of cells morphologically resembling oligodendroglia. Oligodendroglial tumours histologically comprise a continuous spectrum ranging from well-differentiated neoplasms to frankly malignant tumours. WHO grading system recognizes two malignancy grades: WHO grade II for well-differentiated tumours (oligodendroglioma) and WHO grade III for anaplastic oligodendroglioma. (Adapted from WHO) | |||
Revision as of 14:08, 15 August 2026
A neoplasm of the central nervous system composed predominantly of cells morphologically resembling oligodendroglia. Oligodendroglial tumours histologically comprise a continuous spectrum ranging from well-differentiated neoplasms to frankly malignant tumours. WHO grading system recognizes two malignancy grades: WHO grade II for well-differentiated tumours (oligodendroglioma) and WHO grade III for anaplastic oligodendroglioma. (Adapted from WHO)
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | ID_805811519 |
||
| English | Oligodendroglial tumours |
A neoplasm of the central nervous system composed predominantly of cells morphologically resembling oligodendroglia. Oligodendroglial tumours histologically comprise a continuous spectrum ranging from well-differentiated neoplasms to frankly malignant tumours. WHO grading system recognizes two malignancy grades: WHO grade II for well-differentiated tumours (oligodendroglioma) and WHO grade III for anaplastic oligodendroglioma. (Adapted from WHO) |
